Literature DB >> 17651377

Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren.

Fazil Orhan1, Taner Karakas, Murat Cakir, Nevzat Akkol, Elif Bahat, Fatma Mujgan Sonmez, Yusuf Gedik.   

Abstract

Epidemiologic studies about the prevalence of adverse drug reactions in children are scarce compared to reports in adults. To assess the prevalence of parental-reported drug allergy in 6- to 9-yr-old urban school children, we performed a cross-sectional study of 6- to 9-yr-old urban children from the eastern Black Sea region of Turkey during the year 2004, using a self-administered questionnaire by parents. Response rate was 81.6% (2855/3500). The prevalence of parental-reported drug allergy was 2.8% (81/2855). The most common parental-reported drugs were penicillins and other beta-lactams (59.3%), trimethoprim-sulfamethoxazole (11.1%), and acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (NSAIDs) (9.9%). The most commonly reported clinical manifestations were cutaneous (n = 76, 93.8%) followed by gastrointestinal (n = 17, 21%) symptoms. In 19 (23.5%) children, the reaction involved more than one organ system. Of these 19 children, 14 used beta-lactams. Systemic reactions were not reported with NSAIDs. Medications were taken by mouth in 88.9% of the reactions. Most of the reported allergic reactions occurred in the first day of treatment (61.7%). The reported time to reaction after the last intake of the drug was <2 h in 35 (43.2%) children and 2-24 h in 45 (55.6%). Oral reactions occurred later than reactions to parentally administered drugs. Parents of 58 children (71.6%) reported that they completely avoided the suspected culprit drug following the reaction. Relapse occurred after re-administration of the drug in 21 (25.9%) children. A diagnostic approach for drug allergy was not undertaken in any of the children. This study may provide some information about the prevalence of drug allergy, although it is based on parental perception and results are unlikely to conform well to true prevalence.

Entities:  

Mesh:

Year:  2007        PMID: 17651377     DOI: 10.1111/j.1399-3038.2007.00592.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.

Authors:  Tugba Arikoglu; Gulen Aslan; Sehra Birgul Batmaz; Gulcin Eskandari; Ilter Helvaci; Semanur Kuyucu
Journal:  Int J Clin Pharm       Date:  2015-03-31

2.  Knowledge gaps of drug allergy in children: a survey of primary care doctors.

Authors:  Neringa Stirbiene; Odilija Rudzeviciene; Monika Kapitancuke; Neringa Nazarenkaite; Arunas Valiulis
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

Review 3.  Children with reported penicillin allergy: Public health impact and safety of delabeling.

Authors:  David Vyles; James W Antoon; Allison Norton; Cosby A Stone; Jason Trubiano; Alexandra Radowicz; Elizabeth J Phillips
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-26       Impact factor: 6.347

4.  Drug hypersensitivity in students from São Paulo, Brazil.

Authors:  Luis Felipe Chiaverini Ensina; Maria Helena Lopes Amigo; Thais Koch; Evelyn Guzman; Renata Paoli; Inês Cristina Camelo Nunes
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Mild to moderate hypersensitivity reactions to beta-lactams in children: a single-centre retrospective review.

Authors:  Leticia Vila; Vanesa Garcia; Oihana Martinez Azcona; Loreley Pineiro; Angela Meijide; Vanesa Balboa
Journal:  BMJ Paediatr Open       Date:  2019-04-29

6.  Assessing the quality of paediatric antibiotic prescribing by community paediatricians: a database analysis of prescribing in Lombardy.

Authors:  Daniele Piovani; Antonio Clavenna; Massimo Cartabia; Angela Bortolotti; Ida Fortino; Luca Merlino; Maurizio Bonati
Journal:  BMJ Paediatr Open       Date:  2017-09-11

7.  Pediatric drug hypersensitivity: which diagnostic tests?

Authors:  Francesca Saretta; Francesca Mori; Fabio Cardinale; Lucia Liotti; Fabrizio Franceschini; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.